MDR 3.45% 30.0¢ medadvisor limited

Investor Newsletter - Issue 3, page-2

  1. 3,108 Posts.
    lightbulb Created with Sketch. 84
    Our thinking is often aligned MJ.

    Management simply can’t pump out quarterlies and proclaim success by quoting the improvement on the previous years quarter revenue. They need to announce company making deals that gets new holders on the register and entice the old holders to not sell and continue to accumulate.

    EBOS was one of those deals. 2018 needs another. PDX Inc is a great step to international expansion but it won’t see any traction until the integration is complete which is likely to be Q1 2019.

    EBOS paid 5.75c for a chunk of the register. We’re now 4c. I believe we’re still waiting on an official announcement regarding HPS being binding. Terry White and Zest both were signed a number of months ago. Either EBOS are very happy seeing 4c and looking at another bite or perhaps surprised seeing the share price where it is after paying much more. I tend to agree, it’s possibly a result of the lag in getting all the entities in operation.

    The AGM announcement added the EBOS agreement would $4M revenue over 3 years. It’s very possible there will be an update around October. I’m in the queue waiting to be hit.
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.010(3.45%)
Mkt cap ! $215.0M
Open High Low Value Volume
29.0¢ 30.0¢ 27.5¢ $254.8K 889.6K

Buyers (Bids)

No. Vol. Price($)
2 39326 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 2917 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.